Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Cantor Fitzgerald
Fuji
Federal Trade Commission
UBS
Teva
Accenture
Healthtrust
Colorcon

Generated: August 17, 2017

DrugPatentWatch Database Preview

METHAMPHETAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Methamphetamine Hydrochloride, and when can generic versions of Methamphetamine Hydrochloride launch?

Methamphetamine Hydrochloride is a drug marketed by Able, Rexar, West-ward Pharms Int, Teva, and Mayne Pharma Inc. and is included in five NDAs.

The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.

Summary for Tradename: METHAMPHETAMINE HYDROCHLORIDE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list3
Bulk Api Vendors: see list48
Clinical Trials: see list2,365
Patent Applications: see list4,745
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHAMPHETAMINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: METHAMPHETAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Able
METHAMPHETAMINE HYDROCHLORIDE
methamphetamine hydrochloride
TABLET;ORAL040529-001Feb 25, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
METHAMPHETAMINE HYDROCHLORIDE
methamphetamine hydrochloride
TABLET;ORAL203846-001Nov 17, 2015AARXNoNo► Subscribe► Subscribe► Subscribe
Rexar
METHAMPHETAMINE HYDROCHLORIDE
methamphetamine hydrochloride
TABLET;ORAL084931-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Rexar
METHAMPHETAMINE HYDROCHLORIDE
methamphetamine hydrochloride
TABLET;ORAL084931-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma Inc
METHAMPHETAMINE HYDROCHLORIDE
methamphetamine hydrochloride
TABLET;ORAL091189-001Apr 21, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Colorcon
Harvard Business School
Argus Health
US Army
Medtronic
Cantor Fitzgerald
Moodys
Daiichi Sankyo
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot